Aloe vera
Aloe vera

Aloe vera for drinks and shots, and why inner leaf decides the whole product

Aloe barbadensis
Inner leaf or whole leaf, aloin limits, drinks and shots, and why the EU position on aloe leaf preparations needs checking before launch.
Cross-sections of aloe vera leaf showing the clear inner leaf gel

This article tells you what a decolourised gel concentrate can and cannot be used for, how it behaves in a drink, and why the European position needs checking before launch.

One aloe leaf yields two different materials and they are not interchangeable

Aloe barbadensis is a cultivated crop grown across the subtropics, and the leaf is the only part of commercial interest. Two entirely different materials come out of it. The inner leaf gel is a polysaccharide matrix. The layer immediately beneath the rind carries anthraquinones, principally aloin.

Almost every failed aloe specification comes back to which of those two a material is derived from. Inner leaf material is made by filleting, where the rind and the layer beneath it are cut away before the gel is processed. Whole leaf material is milled with the rind included and then treated to remove the anthraquinone fraction.

A decolourised gel concentrate is not a laxative ingredient, and that decides the product

If you are building a product for the anthraquinone laxative trade, a decolourised gel concentrate is the wrong starting material and you need a different one. Saying so plainly costs a small number of enquiries and saves a much larger number of failed specifications.

The reverse mistake is just as common. Buyers sometimes refuse a gel-derived concentrate because they have read about the European action on aloe, which was about the anthraquinone fraction and not about the gel. Aloe sits in digestive health with two incompatible corners inside it, and a brand owner who has not decided which corner they are in has not written a brief yet.

Drinks, shots and gels are the formats, and each asks for something different

Aloe concentrate is a liquid-format ingredient before it is anything else. Beverages, shots and oral liquids are where it does most of its work, with topicals as a separate business. Capsules and tablets are possible but they waste what makes the ingredient interesting.

Beverages want clarity, or a controlled and deliberate cloud, and no sedimentation over shelf life. Shots tolerate more body and more colour. Topicals bring their own preservative and compatibility questions and should be scoped as a separate project. Decide the format before you agree the specification, because the drying route and any carrier are chosen for a format.

Reconstitution ratio, mouthfeel and the heat step are the real problems

Two hundred parts of starting material to one part of finished extract is a real number and it is the number you dose-calculate from when reconstituting to a gel equivalent. Get that calculation agreed in writing at the start.

Mouthfeel is the next problem. The polysaccharide fraction contributes viscosity, and at a working inclusion rate that changes how a drink pours and how a consumer judges it. The third problem is heat. Most beverage and shot formats need pasteurisation or hot fill, and a polysaccharide is a polymer whose behaviour shifts with heat and holding time.

The European position on aloe leaf preparations needs re-checking before launch

In the European Union, aloe leaf preparations containing hydroxyanthracene derivatives, and related anthraquinone substances, have been subject to restriction in foods since 2021, and that position has been under challenge and review since. Many published summaries no longer reflect where it stands.

For a formulator the practical point is the fraction. A decolourised inner leaf gel concentrate with a controlled aloin limit is a different material from a whole leaf or anthraquinone-bearing preparation, and the fraction decides which rules you need to check.

For a launch this means one thing: confirm the current position for your market with your regulatory adviser immediately before you commit.

In the United States the practical point is Proposition 65 in California, which added “Aloe vera, non-decolorized whole leaf extract” to its list in December 2015. That is another reason the decolourised inner leaf route matters commercially.

Aloe is a bought agricultural crop, so ask about fraction and aloin, not origin

There is no origin story to sell here. Aloe is a cultivated commodity sourced to specification, not an African endemic wild-harvest line, so the questions that matter are about control rather than provenance.

Ask which fraction the material is derived from, inner leaf or whole leaf, and get it stated on the specification rather than in an email. Ask for the aloin limit on incoming material, the decolourisation route, the drying route and any carrier.

Questions brand owners ask

Can I build a laxative product on a 200:1 gel concentrate?

No. That product needs an anthraquinone-bearing material and a decolourised gel concentrate is the opposite of one. Decide which of the two products you are making before you brief a supplier.

Is aloe still restricted in the European Union?

The position on aloe leaf preparations and related anthraquinones has been under challenge and review since 2021. Treat any position you write down as provisional, date it, and confirm it with your regulatory adviser before launch.

What does 200:1 actually mean for my label?

It is the ratio of starting material to finished extract, and a gel-equivalent calculation is built from it. Agree that calculation with your supplier and your regulatory reviewer before any front-of-pack figure is designed.

Will it survive my pasteuriser?

That is a question for a trial, not for a datasheet. Run it in your own base at your own time and temperature, and look at viscosity and sedimentation across the full shelf life.

What should I put in the purchase specification?

Plant fraction, aloin limit, decolourisation route, drying route and carrier, plus the reconstitution ratio. A certificate of analysis that omits the fraction and the aloin figure has not answered the two questions a regulator will ask first.

How Afriplex supplies aloe vera

We supply Aloe Vera 200:1 PE, a concentrated powder extract, within our NOVEL-T™ range and against a certificate of analysis. Because extraction and finished dosage form manufacture, including oral liquids, sit in one licensed organisation in Paarl, a drink or shot can be developed and filled without a technology transfer between an extract supplier and a filler. Specifications are available on request.

This article describes a botanical ingredient supplied to businesses for formulation. It is not directed at consumers, it does not describe a finished product, and nothing in it is a therapeutic claim or medical advice. Regulatory classification varies by country.
At a glance
Botanical name
Aloe barbadensis
Family
Asphodelaceae
Plant part
Inner leaf gel
Origin
Cultivated crop, sourced to specification
Provenance
Not African
Characteristic constituents
Polysaccharides, with aloin controlled out
Forms supplied
200:1 concentrated powder extract
Governing instrument
EU position on aloe leaf preparations under review; confirm before launch
From this plant

Reviewed by Afriplex Regulatory Department

/  Botanical Library

More from the Botanical Library

Sliced ginger rhizome with capsules of powdered root on a wooden spoon and a green leaf
Respiratory Support

African ginger

Siphonochilus aethiopicus
Siphonochilus aethiopicus is Critically Endangered and CITES-listed. What ethical supply must show, and how the rhizome behaves in lozenges and syrups.
Ashwagandha (Withania somnifera) roots and root powder on a wooden board
Calm & Mental Wellbeing

Ashwagandha

Withania somnifera
Why a pan-European ashwagandha launch built on one regulatory assumption fails, which formats suit it, and what to ask a supplier.
Baobab tree (Adansonia digitata) in an arid savanna landscape
Cosmetic · Digestive Health · Everyday Vitality

Baobab

Adansonia digitata L.
Baobab powder and baobab oil for brand owners: formats, EU novel food and US GRAS status, vitamin C claim arithmetic, cosmetic rules and traceability.
/  Integration

An Integrated Innovation Company

Afriplex integrates botanical science, formulation development, analytical testing, regulatory affairs, stability services, and GMP manufacturing within a single organisation.

This enables a continuous pathway from early-stage innovation to global commercial supply—delivering consistency, speed, and scientific reliability.